Advisors Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.57M | Buy |
12,119
+3,337
| +38% | +$1.88M | 0.1% | 275 |
|
|
2026
Q1 | $5.21M | Buy |
8,782
+1,758
| +25% | +$876K | 0.09% | 316 |
|
|
2025
Q4 | $3.42M | Buy |
7,024
+2,288
| +48% | +$1.07M | 0.06% | 428 |
|
|
2025
Q3 | $1.99M | Buy |
4,736
+723
| +18% | +$243K | 0.03% | 600 |
|
|
2025
Q2 | $1.15M | Buy |
4,013
+121
| +3% | +$36.2K | 0.02% | 730 |
|
|
2025
Q1 | $1.2M | Buy |
3,892
+1,129
| +41% | +$387K | 0.02% | 704 |
|
|
2024
Q4 | $975K | Sell |
2,763
-2,024
| -42% | -$744K | 0.02% | 745 |
|
|
2024
Q3 | $1.72M | Sell |
4,787
-196
| -4% | -$66.2K | 0.03% | 604 |
|
|
2024
Q2 | $1.59M | Sell |
4,983
-149
| -3% | -$39.4K | 0.03% | 601 |
|
|
2024
Q1 | $1.18M | Sell |
5,132
-1,819
| -26% | -$410K | 0.02% | 700 |
|
|
2023
Q4 | $1.53M | Sell |
6,951
-896
| -11% | -$207K | 0.03% | 607 |
|
|
2023
Q3 | $1.77M | Buy |
7,847
+143
| +2% | +$32.9K | 0.04% | 546 |
|
|
2023
Q2 | $1.7M | Sell |
7,704
-116
| -1% | -$25.7K | 0.03% | 570 |
|
|
2023
Q1 | $1.75M | Buy |
7,820
+1,468
| +23% | +$362K | 0.04% | 555 |
|
|
2022
Q4 | $1.77M | Buy |
6,352
+4,605
| +264% | +$1.16M | 0.04% | 541 |
|
|
2022
Q3 | $366K | Sell |
1,747
-228
| -12% | -$51K | 0.01% | 1013 |
|
|
2022
Q2 | $465K | Sell |
1,975
-1,212
| -38% | -$246K | 0.01% | 961 |
|
|
2022
Q1 | $572K | Sell |
3,187
-22
| -0.7% | -$4.19K | 0.01% | 967 |
|
|
2021
Q4 | $693K | Buy |
3,209
+375
| +13% | +$73.6K | 0.01% | 917 |
|
|
2021
Q3 | $523K | Buy |
2,834
+362
| +15% | +$71.3K | 0.01% | 979 |
|
|
2021
Q2 | $444K | Buy |
2,472
+774
| +46% | +$147K | 0.01% | 1045 |
|
|
2021
Q1 | $284K | Sell |
1,698
-43
| -2% | -$7.17K | ﹤0.01% | 1141 |
|
|
2020
Q4 | $264K | Buy |
1,741
+128
| +8% | +$16.8K | ﹤0.01% | 1139 |
|
|
2020
Q3 | $163K | Buy |
1,613
+747
| +86% | +$82K | ﹤0.01% | 1224 |
|
|
2020
Q2 | $105K | Buy |
866
+860
| +14,333% | +$96.8K | ﹤0.01% | 1297 |
|
|
2020
Q1 | $569 | Hold |
6
| – | – | ﹤0.01% | 1494 |
|
|
2019
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 1546 |
|
|
2019
Q3 | $479 | Hold |
6
| – | – | ﹤0.01% | 1565 |
|
|
2019
Q2 | $366 | Hold |
6
| – | – | ﹤0.01% | 1541 |
|
|
2019
Q1 | $704 | Sell |
6
-601
| -99% | -$70K | ﹤0.01% | 1558 |
|
|
2018
Q4 | $66K | Sell |
607
-103
| -15% | -$11.9K | ﹤0.01% | 1398 |
|
|
2018
Q3 | $91K | Sell |
710
-1,512
| -68% | -$187K | ﹤0.01% | 1372 |
|
|
2018
Q2 | $252K | Sell |
2,222
-261
| -11% | -$28.7K | ﹤0.01% | 1198 |
|
|
2018
Q1 | $288K | Sell |
2,483
-111
| -4% | -$14.1K | ﹤0.01% | 1174 |
|
|
2017
Q4 | $384K | Sell |
2,594
-103
| -4% | -$13.1K | 0.01% | 1127 |
|
|
2017
Q3 | $316K | Sell |
2,697
-708
| -21% | -$90.4K | 0.01% | 1166 |
|
|
2017
Q2 | $442K | Sell |
3,405
-2,082
| -38% | -$260K | 0.01% | 1124 |
|
|
2017
Q1 | $743K | Buy |
5,487
+1,358
| +33% | +$206K | 0.01% | 964 |
|
|
2016
Q4 | $592K | Buy |
4,129
+65
| +2% | +$8.3K | 0.01% | 1057 |
|
|
2016
Q3 | $480K | Sell |
4,064
-218
| -5% | -$26.2K | 0.01% | 1103 |
|
|
2016
Q2 | $454K | Sell |
4,282
-5,883
| -58% | -$656K | 0.01% | 1137 |
|
|
2016
Q1 | $1.13M | Sell |
10,165
-8,661
| -46% | -$1.1M | 0.02% | 823 |
|
|
2015
Q4 | $2.95M | Buy |
18,826
+31
| +0.2% | +$4.51K | 0.05% | 534 |
|
|
2015
Q3 | $2.47M | Sell |
18,795
-7,603
| -29% | -$1.22M | 0.04% | 557 |
|
|
2015
Q2 | $4.59M | Sell |
26,398
-1,484
| -5% | -$267K | 0.06% | 408 |
|
|
2015
Q1 | $4.81M | Sell |
27,882
-4,566
| -14% | -$696K | 0.06% | 384 |
|
|
2014
Q4 | $4.2M | Sell |
32,448
-1,892
| -6% | -$244K | 0.06% | 407 |
|
|
2014
Q3 | $4.42M | Buy |
34,340
+2,519
| +8% | +$260K | 0.06% | 368 |
|
|
2014
Q2 | $2.82M | Buy |
31,821
+5,394
| +20% | +$519K | 0.04% | 490 |
|
|
2014
Q1 | $2.48M | Buy |
26,427
+9,476
| +56% | +$969K | 0.04% | 496 |
|
|
2013
Q4 | $1.92M | Buy |
16,951
+3,850
| +29% | +$347K | 0.03% | 518 |
|
|
2013
Q3 | $1.03M | Buy |
13,101
+5,153
| +65% | +$377K | 0.02% | 664 |
|
|
2013
Q2 | $523K | Buy |
+7,948
| New | +$512K | 0.01% | 843 |
|
Other funds holding UTHR
ACA
JT
Advisors Asset Management's UTHR Position: Q2 2026 in Review
Advisors Asset Management increased its United Therapeutics (UTHR) stake by 38% in Q2 2026, buying an estimated $1.88M and bringing the position to 12,119 shares worth $6.57M. The position accounts for 0.1% of the portfolio, ranked #275.
Advisors Asset Management first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Advisors Asset Management held 12,119 shares of United Therapeutics worth $6.57M as of Q2 2026.
- Advisors Asset Management bought 3,337 United Therapeutics shares in Q2 2026, an estimated $1.88M.
- United Therapeutics made up 0.1% of Advisors Asset Management's portfolio in Q2 2026, its #275 holding.
- Advisors Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.